Pediatric TransplantArchives
Kinetics and Clinical Outcomes of EBV DNAemia in Whole Blood and Plasma Among Pediatric Liver Transplant Recipients: A Single-center Experience.
Pediatric Transplant 1 min.
Data on the course of Epstein-Barr virus (EBV) DNAemia are limited in the pediatric liver transplant (LT) setting. This study aims to analyze the kinetics and clinical outcomes of EBV DNAemia in whole blood (WB) and plasma, and to evaluate the incidence and risk factors for EBV DNAemia, chronic high...
Incidence and risk factors for vascular complications after pediatric liver transplantation: a retrospective two-center comparative study
Pediatric Transplant 1 min.
This study aimed to analyze the pattern and risk factors for vascular complications (VC) in 2 pediatric LTx centers, one in Egypt and the other in the UK. Patients and methods: A retrospective analysis on children undergoing LTx over the years (2015-2020) in group 1 (n = 46 patients; all of them underwent...
Evaluating the impact of pulmonary metastasectomy prior to liver transplantation in pediatric hepatoblastoma patients
Pediatric Transplant 1 min.
Liver transplantation (LT) has improved the outcomes of patients with unresectable hepatoblastoma; however, pulmonary metastases remain a major prognostic challenge. Therefore, we retrospectively evaluated the impact of pulmonary metastasectomy (PM) performed before LT. Methods: Between November 2002...
Hematopoietic Stem Cell Transplantation Achieves Sustained Remission in Pediatric RAS-Associated Autoimmune Lymphoproliferative Disorder with Life-Threatening Complications: a Single-Center Case Series and Literature Review
Pediatric Transplant 1 min.
RAS-associated autoimmune lymphoproliferative disorder (RALD) is a rare disease caused by somatic mutations in KRAS or NRAS genes and is characterized by hepatosplenomegaly, cytopenia, and autoimmune manifestations. Current conventional therapies often yield only transient remission....
